NewsRoom Articles - Page 106 of 214

FridayJul 22, 2022 12:14 pm

Researchers Have Found a New, Fatal Pediatric Subtype of Cancer

Liver cancer is quite rare in children and teens, accounting for only 1% to 2% of pediatric cancers. Even so, it affects around two to three million minors, usually in the first three years of their lives. For the past couple of decades, experts have classified pediatric liver cancers as either hepatocellular or hepatoblastoma carcinomas, with statistics showing that the survival rate for hepatoblastoma after five years is 75% to 80%. Pediatric pathologists have now revealed that there are certain liver cancers whose characteristics do not meet the criteria of the two established carcinoma models. These liver tumors are more…

FridayJul 22, 2022 9:00 am

Successful Early Testing of Concussion Therapy Drives Optimism for Odyssey Health, Inc. (ODYY) as Next-stage Trials are Readied

Medical technology innovator Odyssey Health Inc. is using clinical tests to establish the safety of a therapy designed to treat concussion injuries in its earliest moments The company is enthused by results from the early-stage testing and is preparing to design a Phase II/III trial that will target efficacy results in volunteer subjects, focusing particularly on members of the military Odyssey’s technology combines a synthetic medication with a specially designed application device that helps the medication cross the blood-brain barrier for immediate responsiveness following a mild traumatic brain injury (“mTBI”) Medication for concussion treatment remains an unmet need and Odyssey…

ThursdayJul 21, 2022 10:22 am

Loss of Y Chromosomes in Older Men Elevates Heart Disease Risk, Study Finds

A new study has found that older men losing the Y chromosome in their white blood cells as they age can heighten their risk of death from cardiovascular illnesses and cause severe heart problems. This genetic change, which is scientifically referred to as mosaic Loss of y or mLOY, impacts about 20% of men aged 60 and 40% of those aged 70 and above. The study was carried out by researchers at Sweden’s Uppsala University and the University of Virginia. It was led by Professor Kenneth Walsh of the School of Medicine at the University of Virginia and Associate Professor…

WednesdayJul 20, 2022 10:31 am

Study Reveals Proteins That Can Trigger Immune System Malfunction

At least 20 million Americans live with autoimmune disorders, but there’s still much we don’t know about these conditions. The disorders usually occur when, for some reason, the immune system goes haywire and begins to attack healthy tissue. In addition to not knowing exactly what causes autoimmune disorders, we still haven’t figured out a way to cure them. Recently, however, researchers studying immune disorders discovered a novel method of triggering the immune system via certain proteins. This discovery could provide scientists with the chance to know more about autoimmune conditions such as lupus and scleroderma. Investigators from Weill Cornell Medicine…

WednesdayJul 20, 2022 9:00 am

Odyssey Health, Inc. (ODYY) Responds to Growing Concerns About Concussion Head Injuries with Drug Device in Clinical Trial

As awareness of the long-term hazards of concussive head injuries for young athletes has increased during the past decade, advocates and business enterprises have stepped up to improve coach responsiveness to players’ condition While efforts primarily focus on assessing injury, Odyssey Health Inc. is developing a product it hopes to become the first drug device with FDA approval for treating a concussed patient after injury Odyssey is enrolling patients in a Phase 1 human clinical trial after completing pre-clinical studies in laboratory animals The medical research company’s assets include treatments for patients who may have undiagnosed heart disease, patients choking…

TuesdayJul 19, 2022 12:46 pm

Study Highlights New Insights on Neurological Autoimmune Illnesses

UT Southwestern researchers recently reported that they had used cryoelectron microscopy to obtain the image of an auto-antibody that had bound itself to the surface receptor of a nerve cell. This discovery shows the mechanism behind neurological autoimmune illnesses and may be useful in the development of novel therapies for autoimmune diseases. Autoimmune illnesses are disorders that cause an individual’s immune system to mistakenly attack their body. These illnesses reduce the body’s ability to fight germs such as viruses and bacteria, which in turn, makes individuals susceptible to infections. Common autoimmune illnesses include systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis,…

TuesdayJul 19, 2022 9:45 am

QSAM Biosciences Inc. (QSAM) Marks Milestone with Dosing of First Patient in CycloSam Clinical Trial

Treating patients with primary or secondary bone cancer remains goal, says company CEO Radiopharmaceuticals is a new class of drugs that delivers radiation therapy directly to cancer cells QSAM is working to develop CycloSam(R) as a breakthrough therapeutic for adult and pediatric bone cancer patients QSAM Biosciences (OTCQB: QSAM), a company developing a new class of drugs called radiopharmaceuticals, is leading the charge to evaluate a new treatment for bone cancer and other related, underserved diseases. The company’s pioneering efforts are evident as the first patient has completed treatment in the company’s clinical trial designed to study the effect of its…

MondayJul 18, 2022 9:53 am

Preclinical Study Uncovers Potential Key to Treating Deadly Brain Tumors

A new study has found an alternative approach that would make immunotherapy treatments more effective when treating brain tumors. Immunotherapy drugs are usually used to treat a range of cancers. However, glioblastoma multiforme, which is a fatal type of cancer, remains resistant to this revolutionary treatment because the immune system finds it hard to detect and target these tumors, allowing them to grow undisturbed. Researchers have been looking for ways to treat this deadly cancer whose tumors are usually hidden behind the blood-brain barrier. This location hinders drugs from crossing into the central nervous system’s fluid. For their research, the…

FridayJul 15, 2022 11:02 am

Scientists Identify Gene Behind Pediatric Bone Cancer

Scientists at the Lineberger Comprehensive Cancer Center, University of North Carolina have found that the OTUD7A gene impacts Ewing sarcoma development. Ewing sarcoma is a type of cancer that develops primarily in children and affects bones or tissues surrounding the bones. Figures show that roughly 250 young adults and children are diagnosed with this rare cancer annually in the United States. Of this number, about one-half eventually succumb to the illness, which points to the need for better treatments. The researchers, who collaborated with Atomwise Inc. on this study, published their findings in the “Advanced Science” journal. Pengda Liu, co-lead…

ThursdayJul 14, 2022 11:30 am

Study Maps How Brain Changes During Treatment for Depression

New research has mapped how an individual’s brain changes as they undergo treatment for depression. The study, which was carried out by scientists from the University of British Columbia, was focused on finding out what happened in the brain when a person underwent repetitive transcranial magnetic stimulation. This noninvasive treatment uses magnetic fields to stimulate nerve cells in an individual’s dorso-lateral prefrontal cortex. This region of the brain is involved in mood regulation. This particular treatment is usually administered when other treatment strategies, such as drugs, haven’t effectively helped a patient manage their depression. Various studies have found that antidepressants…